July 16 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS EXTENDS AND ENHANCES COMMERCIAL AGREEMENT TO PROMOTE VISTITAN IN CANADA
* AEQUUS PHARMACEUTICALS INC - AGREED TO NEW TERMS FOR ITS PROMOTIONAL SERVICE AGREEMENT WITH SANDOZ ON VISTITAN
* AEQUUS PHARMACEUTICALS INC - AEQUUS & SANDOZ SPLIT REVENUES BASED UPON AN AGREED TO TIERED STRUCTURE OVER TERM
* AEQUUS PHARMACEUTICALS INC - TERM HAS BEEN EXTENDED TO JUNE 2021, WITH OPTION FOR RENEWAL IF MUTUALLY AGREED TO
* AEQUUS - WITH AMENDMENT, REVENUE SPLITS OF VISTITAN AS OF 2019 TO INCREASE FROM ORIGINAL TIERING SCHEDULE BY AN ADDITIONAL 7% OF NET PRODUCT SALES
* AEQUUS - ALSO ON MILESTONES FULFILLMENT, REVENUE SPLITS OF VISTITAN AS OF 2019 TO INCREASE FROM ORIGINAL TIERING SCHEDULE UP TO ADDITIONAL 12%